Viewing Study NCT06052566


Ignite Creation Date: 2025-12-24 @ 4:38 PM
Ignite Modification Date: 2026-01-02 @ 2:59 AM
Study NCT ID: NCT06052566
Status: COMPLETED
Last Update Posted: 2025-10-22
First Post: 2023-09-18
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of Efinopegdutide in Participants With Hepatic Impairment (MK-6024-014)
Sponsor: Merck Sharp & Dohme LLC
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: 6024-014
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators